Home › Sickle Cell Disease › Ohio
Pag-aaral pangklinika para sa Sickle Cell Disease sa Ohio
22 pag-aaral para sa Sickle Cell Disease ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07187973A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Univ Hosp Cleveland Med Ctr, Cleveland
- Ohio State Univ Wexner Med Ctr, Columbus
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06612268Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
- University Hospitals Case Medical Center, Cleveland
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 12 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT02824471A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0028, Cleveland
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Akron Children's Hospital - Showers Center for Cancer & Blood Disorders, Akron
- Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati
- University of Cincinnati Medical Center Hemophilia Treatment Center, Cincinnati
- at 5 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Cincinnati, Cincinnati
- The Ohio State University, Columbus
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06699849Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
- University of Cincinnati College of Medicine, Cincinnati
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 14 hanggang 80 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT06725550Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Ohio State University, Columbus
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07224360Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 1/2
Edad 12 hanggang 50 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT04819841Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT04093986Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Nationwide Children's Hospital (NT-DMT), Columbus
Nagre-recruitObservasyonal na pag-aaral
Edad 3 hanggang 20 · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06941389A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruit
Edad 13 hanggang 21 · Lahat ng kasarian · Na-update May 11, 2026 · NCT06290401Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- The Ohio State University Medical Center, Columbus
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT06919224Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Cincinnati Children's Hospital, Cincinnati
Nagre-recruitPhase 2
Edad 15 hanggang 40 · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06260891Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 2
Edad 2 hanggang 25 · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT03587272MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
- UH Seidman Cancer Center Adult SCD Clinic or UH Rainbow Babies and Children's Hospital Sickle Cell Anemia Center, Cleveland
Nagre-recruit
Edad 14 pataas · Lahat ng kasarian · Na-update Ene 29, 2026 · NCT06853158A Long-term Follow-up Study in Patients Who Received BEAM-101
- University Hospitals Clevland Medical Center, Cleveland
- The Clevland Clinic Foundation, Cleveland
Nagre-recruitObservasyonal na pag-aaral
Edad 14 hanggang 37 · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT07373639Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitObservasyonal na pag-aaral
6 Months – 6 Years · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07356050Integrative Training Program for Pediatric Sickle Cell Pain
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruit
Edad 12 hanggang 18 · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT06691867Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 4
6 Months · Lahat ng kasarian · Na-update Set 16, 2025 · NCT07177300HPC Offered for PRESERVE Expansion
- The Ohio State University Medical Center, Columbus
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2025 · NCT07145411Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- Cleveland Clinic, Cleveland
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2025 · NCT06385886Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.